ARLYNNA HENDRIX: Open Payments
NPI 1841828464 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 113 payments from 24 companies in 2025. Trend: 2023 $932 · 2024 $1,682 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $307 |
| AstraZeneca Pharmaceuticals LP | 14 | $253 |
| Novo Nordisk Inc | 12 | $217 |
| GlaxoSmithKline, LLC. | 11 | $157 |
| Lilly USA, LLC | 9 | $136 |
| Verona Pharma, Inc. | 7 | $99 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| GENZYME CORPORATION | 2 | $48 |
| Astellas Pharma US Inc | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: BREZTRI, Ozempic, VRAYLAR, MOUNJARO, Ohtuvayre, QULIPTA, TRELEGY ELLIPTA, UBRELVY.
Industry payments across MO — which companies pay providers there.
